Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

The weight-loss drug boom has become one of the internet's biggest scams
Tags Drugs Health care industry Cyber Report
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags GE HealthCare Technologies Inc Novo Nordisk A/S Healthy Returns
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Goodrx Holdings Inc Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Business News Biotech and Pharmaceuticals Health care industry
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags DICK'S Sporting Goods Inc Technology Business News
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Breaking news Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Tags Biotech and Pharmaceuticals Amgen Inc Health care industry
From CNBC.com News
Cramer's Lightning Round: Eli Lilly is a buy
Tags Business Investing Coinbase Global Inc
From CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
Tags Business News Moderna Inc Stock Picks
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Novo Nordisk A/S Biotechnology US: News
From CNBC.com News
‘Two-stocks’ are better than one? Repacking ‘pair trades'
Tags Intel Corp stocks Markets
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Health & Science LILLY DRN Healthy Returns
From CNBC.com News
Jim Cramer says CEOs must properly explain the bad news in every quarter
Tags stocks NVIDIA Corp Mad Money
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags Breaking news Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
Tags Business News Biotech and Pharmaceuticals Business
From CNBC.com News
Jim Cramer's top 10 things to watch in the stock market Wednesday
Tags Investment strategy Starbucks Corp Meta Platforms Inc
From CNBC.com News
Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance
Tags US: News Business Biotechnology
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags LILLY DRN Caterpillar Inc Advanced Micro Devices Inc
From CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
Tags Caterpillar Inc Amazon/com Inc Merck & Co Inc
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags LILLY DRN Science Companies
From CNBC.com News
Cramer's Lightning Round: 'Wait for a pullback' with Eli Lilly
Tags Market Outlook LILLY DRN Business News
From CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Microsoft Corp
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Tags Pharmaceuticals Business US: News
From CNBC.com News
KKM Financial's Essential 40 stock fund is now an ETF
Tags Exchange/traded funds Waste Management Inc JPMorgan Chase & Co
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Novo Nordisk A/S Social issues Healthy Returns
From CNBC.com News
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
Tags Social issues Europe Politics LILLY DRN
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Tencent Holdings Ltd Ford Motor Co Tesla Inc
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags LILLY DRN Politics Tesla Inc
From CNBC.com News
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
Tags Business News Business Health care industry
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.